Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study

被引:179
作者
Neuman, Jennifer [1 ]
Korenstein, Deborah [2 ]
Ross, Joseph S. [3 ,4 ]
Keyhani, Salomeh [5 ,6 ]
机构
[1] Mt Sinai Sch Med, Dept Prevent Med, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA
[3] Yale Univ, Dept Med, Sect Gen Internal Med, Sch Med, New Haven, CT 06520 USA
[4] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06520 USA
[5] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA
[6] VA Med Ctr, HSR&D Res Enhancement Award Program, San Francisco, CA 94121 USA
来源
BRITISH MEDICAL JOURNAL | 2011年 / 343卷
关键词
PHARMACEUTICAL-INDUSTRY; DISCLOSURE; AUTHORS;
D O I
10.1136/bmj.d5621
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To determine the prevalence of financial conflicts of interest among members of panels producing clinical practice guidelines on screening, treatment, or both for hyperlipidaemia or diabetes. Design Cross sectional study. Setting Relevant guidelines published by national organisations in the United States and Canada between 2000 and 2010. Participants Members of guideline panels. Main outcome measures Prevalence of financial conflicts of interest among members of guideline panels and chairs of panels. Results Fourteen guidelines met our search criteria, of which five had no accompanying declaration of conflicts of interest by panel members. 288 panel members had participated in the guideline development process. Among the 288 panel members, 138 (48%) reported conflicts of interest at the time of the publication of the guideline and 150 (52%) either stated that they had no such conflicts or did not have an opportunity to declare any. Among 73 panellists who formally declared no conflicts, 8 (11%) were found to have one or more. Twelve of the 14 guideline panels evaluated identified chairs, among whom six had financial conflicts of interest. Overall, 150 (52%) panel members had conflicts, of which 138 were declared and 12 were undeclared. Panel members from government sponsored guidelines were less likely to have conflicts of interest compared with guidelines sponsored by non-government sources (15/92 (16%) v 135/196 (69%); P<0.001). Conclusions The prevalence of financial conflicts of interest and their under-reporting by members of panels producing clinical practice guidelines on hyperlipidaemia or diabetes was high, and a relatively high proportion of guidelines did not have public disclosure of conflicts of interest. Organisations that produce guidelines should minimise conflicts of interest among panel members to ensure the credibility and evidence based nature of the guidelines' content.
引用
收藏
页数:8
相关论文
共 27 条
[1]  
*AG HEALTHC RES QU, 2007, HOUS PHARM COMP MED
[2]  
[Anonymous], WHO HDB GUID DEV
[3]  
[Anonymous], US PREV SERV TASK FO
[4]   From Disclosure to Transparency The Use of Company Payment Data [J].
Chimonas, Susan ;
Frosch, Zachary ;
Rothman, David J. .
ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (01) :81-86
[5]   Relationships between authors of clinical practice guidelines and the pharmaceutical industry [J].
Choudhry, NK ;
Stelfox, HT ;
Detsky, AS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (05) :612-617
[6]   Conflicts of Interest and Disclosure in the American Psychiatric Association's Clinical Practice Guidelines [J].
Cosgrove, Lisa ;
Bursztajn, Harold J. ;
Krimsky, Sheldon ;
Anaya, Maria ;
Walker, Justin .
PSYCHOTHERAPY AND PSYCHOSOMATICS, 2009, 78 (04) :228-232
[7]   Towards more uniform conflict disclosures [J].
不详 .
BRITISH MEDICAL JOURNAL, 2010, 340
[8]   Practice guidelines developed by specialty societies: the need for a critical appraisal [J].
Grilli, R ;
Magrini, N ;
Penna, A ;
Mura, G ;
Liberati, A .
LANCET, 2000, 355 (9198) :103-106
[9]   The Vexing Problem of Guidelines and Conflict of Interest: A Potential Solution [J].
Guyatt, Gordon ;
Akl, Elie A. ;
Hirsh, Jack ;
Kearon, Clive ;
Crowther, Mark ;
Gutterman, David ;
Lewis, Sandra Zelman ;
Nathanson, Ian ;
Jaeschke, Roman ;
Schuenemann, Holger .
ANNALS OF INTERNAL MEDICINE, 2010, 152 (11) :738-741
[10]   Invited article: Conflicts of interest for authors of American Academy of Neurology clinical practice guidelines [J].
Holloway, R. G. ;
Mooney, C. J. ;
Getchius, T. S. D. ;
Edlund, W. S. ;
Miyasaki, J. .
NEUROLOGY, 2008, 71 (01) :57-63